Apollomics (APLM) Operating Leases (2021 - 2025)
Apollomics' (APLM) quarterly Operating Leases came in at $434000.0 in Q4 2025, down 40.79% year-over-year from $733000.0 in Q4 2024, and down 19.78% quarter-over-quarter from $541000.0 in Q2 2025.
Analysis
Apollomics (APLM) Operating Leases (2021 - 2025) Analysis & Trends
Apollomics (APLM) has reported Operating Leases for 5 consecutive years, with $434000.0 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Operating Leases fell 40.79% year-over-year to $434000.0 in Q4 2025; TTM through Dec 2025 was $434000.0, a 40.79% decrease from a year earlier, with the FY2025 full-year figure at $434000.0, down 40.79% from the prior year.
- Operating Leases was $434000.0 for Q4 2025 at Apollomics, down from $541000.0 in the prior quarter.
- Over five years, Operating Leases peaked at $338.4 million in Q4 2021 and troughed at $267000.0 in Q4 2023.
- A 5-year average of $42.8 million and a median of $556000.0 in 2022 frame the typical range for Operating Leases.
- Across the five-year window, Operating Leases sank 99.89% in 2022 and surged 174.53% in 2024, its largest moves.
- Over 5 years, Operating Leases stood at $338.4 million in 2021, then slumped by 99.89% to $377000.0 in 2022, then dropped by 29.18% to $267000.0 in 2023, then jumped by 174.53% to $733000.0 in 2024, then sank by 40.79% to $434000.0 in 2025.
- The last three Operating Leases figures came in at $434000.0 (Q4 2025), $541000.0 (Q2 2025), and $733000.0 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Apollomics | 34.50 Mn | 31.23 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 434,000.00 |
| Jun 30, 2025 | 541,000.00 |
| Dec 31, 2024 | 733,000.00 |
| Jun 30, 2024 | 900,000.00 |
| Dec 31, 2023 | 267,000.00 |
| Dec 31, 2022 | 377,000.00 |
| Jun 30, 2022 | 571,000.00 |
| Dec 31, 2021 | 338.42 Mn |